PUBLICATIONS

  • Scientific publications

    • Donners R, Krieg AH, Baumhoer D, Boll DT, Harder D. Quantitative signal intensity ratios to distinguish between subfascial lipoma and atypical lipomatous tumor/well-differentiated liposarcoma using short-tau inversion recovery (STIR) MRI. Diagn Interv Imaging. 2020 Jun;101(6):383-390. doi: 10.1016/j.diii.2020.01.015. Epub 2020 Feb 24. PMID: 32107197.

    • Mumme M, Wixmerten A, Miot S, Barbero A, Kaempfen A, Saxer F, Gehmert S, Krieg A, Schaefer DJ, Jakob M, Martin I. Tissue engineering for paediatric patients. Swiss Med Wkly. 2019 Apr 5;149:w20032. doi: 10.4414/smw.2019.20032. PMID: 30950502.
    • Baumhoer D, Kovac M, Sperveslage J, Ameline B, Strobl AC, Krause A, Trautmann M, Wardelmann E, Nathrath M, Höller S, Hardes J, Gosheger G, Krieg AH, Vieth V, Tirabosco R, Amary F, Flanagan AM, Hartmann W. Activating mutations in the MAP- kinase pathway define non-ossifying fibroma of bone. J Pathol. 2019 May;248(1):116-122. doi: 10.1002/path.5216. Epub 2019 Jan 24. PMID: 30549028.
    • Willburger JCF, Kettelhack C, Fuchs B, Schaefer DJ, Osinga R. Giant myxoid liposarcoma of the gluteal region: case report of patient caused delay of surgical treatment and review of the literature. J Surg Case Rep. 2018 Oct 8;2018(10):rjy265. doi: 10.1093/jscr/rjy265. PMID: 30310650; PMCID: PMC6174623.
    • Lenze U, Kasal S, Hefti F, Krieg AH. Non-vascularised fibula grafts for reconstruction of segmental and hemicortical bone defects following meta- /diaphyseal tumour resection at the extremities. BMC Musculoskelet Disord. 2017 Jul 5;18(1):289. doi: 10.1186/s12891-017-1640-z. PMID: 28679368; PMCID: PMC5499012.
    • Longhi A, Bielack SS, Grimer R, Whelan J, Windhager R, Leithner A, Gronchi A, Biau D, Jutte P, Krieg AH, Klenke FM, Grignani G, Donati DM, Capanna R, Casanova J, Gerrand C, Bisogno G, Hecker-Nolting S, De Lisa M, D’Ambrosio L, Willegger M, Scoccianti G, Ferrari S. Extraskeletal osteosarcoma: A European Musculoskeletal Oncology Society study on 266 patients. Eur J Cancer. 2017 Mar;74:9-16. doi: 10.1016/j.ejca.2016.12.016. Epub 2017 Feb 3. PMID: 28167373.
    • Krieg AH, Gehmert S, Angst R, Rischewski JR, Kühne T, Hefti F. Impact of Single Center Treatment on Ewing Sarcoma 10-Year Long Term Survival Rates. Acta Chir Orthop Traumatol Cech. 2017;84(6):431-435. English. PMID: 29351525.
    • Burckhardt MA, Schifferli A, Krieg AH, Baumhoer D, Szinnai G, Rudin C. Tumor-associated FGF-23-induced hypophosphatemic rickets in children: a case report and review of the literature. Pediatr Nephrol. 2015 Jan;30(1):179-82. doi: 10.1007/s00467-014-2979-0. Epub 2014 Oct 18. PMID: 25326108.
    • Karwacki GM, Stöckli M, Kettelhack C, Mengiardi B, Studler U. Radiographic diagnosis and differentiation of an aggressive angiomyxoma in a male patient. J Radiol Case Rep. 2013 Jul 1;7(7):1-6. doi: 10.3941/jrcr.v7i7.1154. PMID: 24421942; PMCID: PMC3888160.
    • Brotzmann M, Hefti F, Baumhoer D, Krieg AH. Do malignant bone tumors of the foot have a different biological behavior than sarcomas at other skeletal sites? Sarcoma. 2013;2013:767960. doi: 10.1155/2013/767960. Epub 2013 Mar 20. PMID: 23737703; PMCID: PMC3655663.
    • Krol Z, Skadlubowicz P, Hefti F, Krieg AH. Virtual reconstruction of pelvic tumor defects based on a gender-specific statistical shape model. Comput Aided Surg. 2013;18(5-6):142-53. doi: 10.3109/10929088.2013.777973. Epub 2013 Mar 14. PMID: 23488562.
    • Speth BM, Krieg AH, Kaelin A, Exner GU, Guillou L, von Hochstetter A, Jundt G, Hefti F. Synovial sarcoma in patients under 20 years of age: a multicenter study with a minimum follow-up of 10 years. J Child Orthop. 2011 Oct;5(5):335-42. doi: 10.1007/s11832-011-0360-4. Epub 2011 Aug 11. PMID: 23024724; PMCID: PMC3179534.
    • Göpfert B, Krol Z, Freslier M, Krieg AH. 3D video-based deformation measurement of the pelvis bone under dynamic cyclic loading. Biomed Eng Online. 2011 Jul 17;10:60. doi: 10.1186/1475-925X-10-60. PMID: 21762533; PMCID: PMC3155904.
    • Krieg AH, Lenze U, Gaston MS, Hefti F. The outcome of pelvic reconstruction with non-vascularised fibular grafts after resection of bone tumours. J Bone Joint Surg Br. 2010 Nov;92(11):1568-73. doi: 10.1302/0301-620X.92B11.24893. PMID: 21037354.
    • Krieg AH, Hefti F, Speth BM, Jundt G, Guillou L, Exner UG, von Hochstetter AR, Cserhati MD, Fuchs B, Mouhsine E, Kaelin A, Klenke FM, Siebenrock KA. Synovial sarcomas usually metastasize after >5 years: a multicenter retrospective analysis with minimum follow-up of 10 years for survivors. Ann Oncol. 2011 Feb;22(2):458-67. doi: 10.1093/annonc/mdq394. Epub 2010 Aug 17. PMID: 20716627.
    • Moran M, Krieg AH, Boyle RA, Stalley PD. Bilateral total hip arthroplasty in Severe Hereditary Multiple Exostosis: a report of two cases. Hip Int. 2009 Jul- Sep;19(3):279-82. doi: 10.1177/112070000901900316. PMID: 19876885.
    • Beck TM, Rasch H, Bruder E, Hügli RW, Kettelhack C. Myositis Ossificans Presenting as a Tumor of the Cervical Paraspinal Muscles. Eur J Trauma Emerg Surg. 2010 Jun;36(3):257-9. doi: 10.1007/s00068-009-8094-4. Epub 2009 May 7. PMID: 26815871.
    • Krieg AH, Mani M, Speth BM, Stalley PD. Extracorporeal irradiation for pelvic reconstruction in Ewing’s sarcoma. J Bone Joint Surg Br. 2009 Mar;91(3):395-400. doi: 10.1302/0301-620X.91B3.21164. PMID: 19258619.
    • Tunn PU, Kettelhack C, Dürr HR. Standardized approach to the treatment of adult soft tissue sarcoma of the extremities. Recent Results Cancer Res. 2009;179:211-28. doi: 10.1007/978-3-540-77960-5_13. PMID: 19230542.
    • Tunn PU, Fehlberg S, Andreou D, Kettelhack C. Stellenwert der Beckenendoprothetik in der operativen Therapie von Tumoren des knöchernen Beckens [Endoprosthesis in the operative treatment of bone tumours of the pelvis]. Z Orthop Unfall. 2007 Nov-Dec;145(6):753-9. German. doi: 10.1055/s-2007-965757. PMID: 18072042.
    • Baumhoer D, Glatz K, Schulten HJ, Füzesi L, Fricker R, Kettelhack C, Hasenboehler P, Oberholzer M, Jundt G. Myxoinflammatory fibroblastic sarcoma: investigations by comparative genomic hybridization of two cases and review of the literature. Virchows Arch. 2007 Nov;451(5):923-8. doi: 10.1007/s00428-007-0480-x. Epub 2007 Aug 11. PMID: 17694321.
    • Krieg AH, Davidson AW, Stalley PD. Intercalary femoral reconstruction with extracorporeal irradiated autogenous bone graft in limb-salvage surgery. J Bone Joint Surg Br. 2007 Mar;89(3):366-71. doi: 10.1302/0301-620X.89B3.18508. PMID: 17356151.
    • Krieg AH, Hefti F. Reconstruction with non-vascularised fibular grafts after resection of bone tumours. J Bone Joint Surg Br. 2007 Feb;89(2):215-21. doi: 10.1302/0301-620X.89B2.17686. PMID: 17322438.
    • Fueglistaler P, Gurke L, Stierli P, Obeid T, Koella C, Oertli D, Kettelhack C. Major vascular resection and prosthetic replacement for retroperitoneal tumors. World J Surg. 2006 Jul;30(7):1344-9. doi: 10.1007/s00268-005-0555-2. PMID: 16773255.
    • Kettelhack Ch. Die isolierte Extremitäten- perfusion mit Tumor- nekrosefaktor und Melphalan bei fortgeschrittenen Weichgewebssarkomen [Isolated limb perfusion with tumor necrosis factor and melphalan for locally advanced soft tissue sarcoma]. Praxis (Bern 1994). 2004 Nov 24;93(48):2009-12. German. doi: 10.1024/0369-8394.93.48.2009. PMID: 15603312.
    • Hohenberger P, Latz E, Kettelhack C, Rezaei AH, Schumann R, Schlag PM. Pentoxifyllin attenuates the systemic inflammatory response induced during isolated limb perfusion with recombinant human tumor necrosis factor-alpha and melphalan. Ann Surg Oncol. 2003 Jun;10(5):562-8. doi: 10.1245/aso.2003.10.005. PMID: 12794024.
    • Ulmer C, Kettelhack C, Tunn PU, Reichardt P, Hohenberger P, Schlag PM. Synovialsarkome der Extremitäten. Ergebnisse chirurgischer und multimodaler Therapie [Synovial sarcoma of the extremities. Results of surgical and multimodal therapy]. Chirurg. 2003 Apr;74(4):370-4. German. doi: 10.1007/s00104-003-0617-7. PMID: 12719879.
    • Junginger T, Kettelhack C, Schönfelder M, Saeger HD, Rieske H, Krummenauer F, Hermanek P. Therapeutische Strategien bei malignen Weichteiltumoren. Ergebnisse der Weichteiltumor-Registerstudie der CAO [Therapeutic strategies in malignant soft tissue tumors. Results of the soft tissue tumor register study of the Surgical Oncology Working Group]. Chirurg. 2001 Feb;72(2):138-48. German. doi: 10.1007/s001040051281. PMID: 11253672.
    • Kettelhack C, Hohenberger P, Schulze G, Kilpert B, Schlag PM. Induction of systemic serum procalcitonin and cardiocirculatory reactions after isolated limb perfusion with recombinant human tumor necrosis factor-alpha and melphalan. Crit Care Med. 2000 Apr;28(4):1040-6. doi: 10.1097/00003246-200004000-00021. PMID: 10809279.
    • Kettelhack C, Tunn U, Schlag PM. Strategie multimodaler Therapie bei Weichgewebssarkomen des Stammes und der Extremitäten [Strategy for multimodal therapy of soft tissue sarcomas of the trunk and extremities]. Chirurg. 1998 Apr;69(4):393-401. German. doi: 10.1007/s001040050429. PMID: 9612621.
    • Hohenberger P, Kettelhack C. Clinical management and current research in isolated limb perfusion for sarcoma and melanoma. Oncology. 1998 Mar- Apr;55(2):89-102. doi: 10.1159/000011842. Erratum in: Oncology 1998 Jul- Aug;55(4):344. PMID: 9499194.
    • Kettelhack C, Hohenberger P, Furchtbar S, Schulze G, Schlag PM. Procalcitonin als Marker der systemischen inflammatorischen Reaktion nach isolierter Extremitätenperfusion [Procalcitonin as marker of systemic inflammatory reaction after isolated extremity perfusion]. Langenbecks Arch Chir Suppl Kongressbd. 1998;115(Suppl I):399-402. German. PMID: 14518284.
    • Schlag PM, Tunn PU, Kettelhack C. Diagnostisches und therapeutisches Vorgehen bei Weichgewebstumoren [Diagnostic and therapeutic procedures in soft tissue tumors]. Chirurg. 1997 Dec;68(12):1309-17. German. doi: 10.1007/s001040050366. PMID: 9483362.
    • Hohenberger P, Haier J, Kettelhack C, Schulze G, Schlag PM. Erfassung regionaler und systemischer Toxizität der isolierten, hyperthermen Extremitätenperfusion mit Tumor-Nekrose-Faktor alpha und Melphalan [Assessment of regional and systemic toxicity of isolated hyperthermic extremity perfusion with tumor necrosis factor-alpha and melphalan]. Chirurg. 1997 Sep;68(9):914-20. German. doi: 10.1007/s001040050295. PMID: 9410682.
    • Eggermont AM, Schraffordt Koops H, Klausner JM, Kroon BB, Schlag PM, Liénard D, van Geel AN, Hoekstra HJ, Meller I, Nieweg OE, Kettelhack C, Ben-Ari G, Pector JC, Lejeune FJ. Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience. Ann Surg. 1996 Dec;224(6):756-64; discussion 764-5. doi: 10.1097/00000658-199612000-00011. PMID: 8968230; PMCID: PMC1235474.
    • Schlag PM, Kettelhack C. Weichteilsarkome: Die isolierte hypertherme Extremitätenperfusion. Technik und Indikationen [Soft tissue sarcoma: isolated hyperthermic extremity perfusion. Technique and indications]. Chirurg. 1993 Jun;64(6):455-60. German. PMID: 8359057.
    • Kettelhack C, Kraus T, Hupp T, Manner M, Schlag P. Hyperthermic limb perfusion for malignant melanoma and soft tissue sarcoma. Eur J Surg Oncol. 1990 Aug;16(4):370-5. PMID: 2379595.
    • Manner M, Sinn H, Bubeck H, Kettelhack C, Schlag P. Verbesserte intraoperative Leckkontrolle bei der isolierten Zytostatikaperfusion von Extremitätentumoren [Improved intraoperative leak control in cytostatic drug isolation perfusion of tumors of the extremities]. Langenbecks Arch Chir. 1990;375(4):208-13. German. doi: 10.1007/BF00187440. PMID: 2395387.
    • Kettelhack C, Schlag P. Die isolierte hypertherme Extremitätenperfusion mit Zytostatika. Eine Behandlungsmethode bei malignem Melanom und bei Weichteilsarkomen [Isolated hyperthermic perfusion of the extremities with cytostatic agents. A method of treatment in malignant melanoma and soft tissue sarcoma]. Dtsch Krankenpflegez. 1989 Sep;42(9):597-601. German. PMID: 2518209.
  • Press articles